{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "72974-120",
      "generic_name": "relugolix",
      "labeler_name": "Sumitomo Pharma America, Inc.",
      "brand_name": "Orgovyx",
      "active_ingredients": [
        {
          "name": "RELUGOLIX",
          "strength": "120 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "72974-120-01",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-01)",
          "marketing_start_date": "20201218",
          "sample": false
        },
        {
          "package_ndc": "72974-120-95",
          "description": "16 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-95)",
          "marketing_start_date": "20230127",
          "sample": true
        },
        {
          "package_ndc": "72974-120-97",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-97)",
          "marketing_start_date": "20211021",
          "sample": true
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Sumitomo Pharma America, Inc."
        ],
        "rxcui": [
          "2472783",
          "2472789"
        ],
        "spl_set_id": [
          "077a92f6-9f1b-479a-87c7-c92b5db6aa9c"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175839",
          "N0000175084",
          "N0000008638",
          "N0000190118",
          "N0000187064",
          "N0000190113",
          "N0000185503"
        ],
        "pharm_class_epc": [
          "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]",
          "Cytochrome P450 3A Inducers [MoA]",
          "Cytochrome P450 2B6 Inducers [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased GnRH Secretion [PE]"
        ],
        "unii": [
          "P76B05O5V6"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "0d9200dd-878e-4e93-98af-e1149e84c21f",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20201218",
      "product_id": "72974-120_0d9200dd-878e-4e93-98af-e1149e84c21f",
      "application_number": "NDA214621",
      "brand_name_base": "Orgovyx",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 2B6 Inducers [MoA]",
        "Cytochrome P450 3A Inducers [MoA]",
        "Decreased GnRH Secretion [PE]",
        "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]",
        "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}